Preferred Stock and Stockholders' Equity (Narrative) (Details)
|
|
|
|
|
1 Months Ended |
12 Months Ended |
|
|
Feb. 26, 2016
shares
|
Feb. 18, 2015
shares
|
Jul. 06, 2012
USD ($)
$ / shares
shares
|
Mar. 29, 2012
$ / shares
shares
|
Mar. 31, 2015
USD ($)
shares
|
May. 31, 2014
shares
|
Mar. 31, 2008
shares
|
Dec. 31, 2015
USD ($)
item
$ / shares
shares
|
Dec. 31, 2014
USD ($)
$ / shares
shares
|
Dec. 31, 2013
USD ($)
shares
|
Dec. 31, 2012
USD ($)
$ / shares
shares
|
Dec. 31, 2008
USD ($)
|
Apr. 30, 2010
shares
|
| Shareholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares authorized |
|
|
|
|
|
|
|
10,000,000
|
10,000,000
|
|
|
|
|
| Preferred stock, par value | $ / shares |
|
|
|
|
|
|
|
$ 0.001
|
$ 0.001
|
|
|
|
|
| Preferred stock, shares outstanding |
|
|
|
|
|
|
|
0
|
0
|
|
|
|
|
| Stock and warrants issued during period |
|
|
|
|
|
|
8,900,000
|
|
|
|
|
|
|
| Common stock issued during period upon exercise of warrants |
|
|
|
|
|
|
|
|
|
|
216,000
|
|
|
| Warrants to purchase common stock |
|
|
|
|
|
|
4,500,000
|
|
|
|
|
|
|
| Common stock, shares issued |
|
|
11,000,000
|
|
|
|
|
|
|
|
|
|
|
| Common stock, price per share | $ / shares |
|
|
$ 4.49
|
|
|
|
|
|
|
|
|
|
|
| Net sales from sale of common stock | $ |
|
|
$ 46,100,000
|
|
|
|
|
|
|
|
|
|
|
| Proceeds generated | $ |
|
|
|
|
|
|
|
|
|
|
$ 470,000
|
|
|
| Percentage of liquidated damages |
|
|
|
|
|
|
|
|
|
|
|
5.00%
|
|
| Number of additional shares authorized for issuance |
|
|
|
|
|
|
|
4,056,000
|
3,993,000
|
3,992,000
|
|
|
|
| Number of stock option plans | item |
|
|
|
|
|
|
|
2
|
|
|
|
|
|
| Number of shares issuable |
|
|
|
|
|
|
|
10,639,000
|
|
|
|
|
|
| Shares available for future grants |
|
|
|
|
|
|
|
8,070,000
|
7,546,000
|
4,926,000
|
4,055,000
|
|
|
| Total intrinsic value of options exercised | $ |
|
|
|
|
|
|
|
$ 5,500,000
|
$ 3,000,000
|
$ 55,000
|
|
|
|
| Fair value of options vested | $ |
|
|
|
|
|
|
|
$ 5,400,000
|
4,600,000
|
5,000,000
|
|
|
|
| Forfeiture rate, stock option expense |
|
|
|
|
|
|
|
0.00%
|
|
|
|
|
|
| Non-cash stock-based compensation expense | $ |
|
|
|
|
|
|
|
$ 6,013,000
|
$ 5,201,000
|
$ 5,196,000
|
|
|
|
| Common shares issued upon exercise of options |
|
|
|
|
|
|
|
2,041,000
|
1,381,000
|
35,000
|
|
|
|
| Other Non-Operating Expense [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Liquidated damages | $ |
|
|
|
|
|
|
|
|
|
|
|
$ 1,300,000
|
|
| 2004 Equity Incentive Plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares available for future grants |
|
|
|
|
|
|
|
|
|
|
0
|
|
|
| 2012 Stock Option Plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of additional shares authorized for issuance |
|
4,100,000
|
|
|
|
|
|
|
|
|
|
|
|
| Increase in shares available for issuance based on percentage of common stock outstanding |
|
4.00%
|
|
|
|
|
|
|
|
|
|
|
|
| Shares available for future grants |
|
|
|
|
|
|
|
|
|
|
5,300,000
|
|
|
| 2012 Equity Incentive Award Plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Increase in shares available for issuance based on percentage of common stock outstanding |
|
|
|
|
|
|
|
4.00%
|
|
|
|
|
|
| Minimum |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 1.66
|
|
|
| Minimum | 2004 Equity Incentive Plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price as percentage of fair value of common stock |
|
|
|
|
|
|
|
100.00%
|
|
|
|
|
|
| Stock options, vesting period |
|
|
|
|
|
|
|
1 year
|
|
|
|
|
|
| Minimum | 2012 Stock Option Plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price as percentage of fair value of common stock |
|
|
|
|
|
|
|
100.00%
|
|
|
|
|
|
| Stock options, vesting period |
|
|
|
|
|
|
|
1 year
|
|
|
|
|
|
| Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 2.96
|
|
|
| Maximum | 2004 Equity Incentive Plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock options, vesting period |
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
| Maximum | 2012 Stock Option Plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock options, vesting period |
|
|
|
|
|
|
|
4 years
|
|
|
|
|
|
| Non-employee [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of awards outstanding | item |
|
|
|
|
|
|
|
1
|
|
|
|
|
|
| Non-cash stock-based compensation expense | $ |
|
|
|
|
|
|
|
$ 87,000
|
$ 470,000
|
$ 127,000
|
|
|
|
| Unvested shares |
|
|
|
|
|
|
|
17,000
|
|
|
|
|
|
| Subsequent Events | 2012 Equity Incentive Award Plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of additional shares authorized for issuance |
4,400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Employee And Director Stock Option |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Non-cash stock-based compensation expense | $ |
|
|
|
|
|
|
|
$ 6,000,000
|
$ 4,700,000
|
$ 5,100,000
|
|
|
|
| Unrecognized compensation expense | $ |
|
|
|
|
|
|
|
$ 12,700,000
|
|
|
|
|
|
| Unrecognized compensation expense, weighted-average vesting period |
|
|
|
|
|
|
|
2 years 10 months 6 days
|
|
|
|
|
|
| Private Placement 2008 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant exercised on a cashless net-exercise basis |
|
|
|
|
|
529,567
|
|
|
|
|
|
|
|
| Common stock issued during period upon exercise of warrants |
|
|
|
|
|
164,666
|
|
|
|
|
|
|
|
| April 2010 Private Placement |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| New warrants sold to purchase shares of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
4,200,000
|
| Common stock issued during period upon exercise of warrants |
|
|
|
4,200,000
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrants | $ / shares |
|
|
|
$ 2.96
|
|
|
|
|
|
|
|
|
|
| April 2010 and March 2012 Private Placements |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds generated | $ |
|
|
|
|
|
|
|
$ 12,800,000
|
|
|
|
|
|
| Private Placement |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock issued during period upon exercise of warrants |
|
|
|
|
6,200,000
|
|
|
|
|
|
|
|
|
| Exercise price of warrants | $ / shares |
|
|
|
$ 4.05
|
|
|
|
|
|
|
|
|
|
| Number Of Private Placement Transactions | item |
|
|
|
|
|
|
|
2
|
|
|
|
|
|
| Proceeds generated | $ |
|
|
|
|
$ 17,100,000
|
|
|
|
|
|
|
|
|
| Related Parties | March 2012 Private Placement |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of securities sold to related parties |
|
|
|
|
|
|
|
40.00%
|
|
|
|
|
|
| Directors [Member] | Private Placement |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders Equity [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock issued during period upon exercise of warrants |
|
|
|
|
3,100,000
|
|
|
|
|
|
|
|
|
| Proceeds generated | $ |
|
|
|
|
$ 5,900,000
|
|
|
|
|
|
|
|
|